Mark Massaro
Stock Analyst at BTIG
(2.13)
# 1,540
Out of 4,412 analysts
91
Total ratings
42.31%
Success rate
n/a
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Maintains: Buy | $11 → $15 | $11.08 | +35.38% | 1 | Apr 22, 2024 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $6 → $5 | $2.60 | +92.31% | 2 | Apr 4, 2024 | |
| HLTH Cue Health | Downgrades: Neutral | n/a | $0.14 | - | 5 | Mar 14, 2024 | |
| MXCT MaxCyte | Maintains: Buy | $10 → $8 | $3.71 | +115.63% | 3 | Mar 13, 2024 | |
| TKNO Alpha Teknova | Downgrades: Neutral | n/a | $1.73 | - | 1 | Mar 12, 2024 | |
| DMTK DermTech | Maintains: Buy | $4 → $2 | $0.60 | +231.62% | 4 | Mar 7, 2024 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $8 | $2.47 | +223.89% | 8 | Mar 7, 2024 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $7 → $8 | $5.03 | +59.05% | 2 | Mar 6, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $25 → $21 | $14.14 | +48.51% | 3 | Dec 29, 2023 | |
| NTRA Natera | Maintains: Buy | $75 → $85 | $91.66 | -7.27% | 5 | Dec 29, 2023 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Neutral | n/a | $0.86 | - | 3 | Nov 9, 2023 | |
| TLIS Talis Biomedical | Maintains: Sell | $0.35 → $5 | $9.14 | -45.30% | 3 | Aug 16, 2023 | |
| BNGO Bionano Genomics | Maintains: Buy | $2 → $10 | $0.79 | +1,172.10% | 6 | Aug 10, 2023 | |
| CSTL Castle Biosciences | Maintains: Buy | $38 → $30 | $20.34 | +47.49% | 2 | Jun 15, 2023 | |
| RNLX Renalytix | Maintains: Buy | $4 → $3.5 | $0.63 | +456.62% | 3 | Apr 3, 2023 | |
| XGN Exagen | Maintains: Buy | $6 → $5 | $1.41 | +254.11% | 3 | Mar 22, 2023 | |
| CDNA CareDx | Maintains: Buy | $28 → $25 | $7.56 | +230.69% | 2 | Feb 28, 2023 | |
| GH Guardant Health | Maintains: Buy | $60 → $50 | $17.35 | +188.18% | 1 | Feb 24, 2023 | |
| EXAS Exact Sciences | Maintains: Buy | $85 → $80 | $58.85 | +35.94% | 9 | Feb 22, 2023 | |
| CERS Cerus | Downgrades: Neutral | n/a | $1.71 | - | 1 | Jan 20, 2023 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $5 → $3.5 | $0.68 | +412.37% | 2 | Nov 18, 2022 | |
| TTOO T2 Biosystems | Downgrades: Neutral | n/a | $2.84 | - | 2 | Jul 7, 2022 | |
| AKYA Akoya Biosciences | Initiates: Buy | $16 | $3.80 | +321.05% | 1 | Jun 22, 2022 | |
| OCX OncoCyte | Initiates: Buy | n/a | $2.48 | - | 1 | Nov 30, 2020 | |
| AXDX Accelerate Diagnostics | Initiates: Neutral | n/a | $0.93 | - | 1 | Oct 8, 2020 | |
| LH Laboratory Corporation of America Holdings | Maintains: Hold | n/a | $198.40 | - | 4 | Dec 3, 2018 | |
| DGX Quest Diagnostics | Maintains: Buy | n/a | $134.26 | - | 3 | Oct 24, 2018 | |
| HOLX Hologic | Maintains: Hold | n/a | $75.98 | - | 3 | Sep 27, 2018 | |
| QDEL QuidelOrtho | Maintains: Buy | n/a | $39.64 | - | 4 | Sep 10, 2018 | |
| ILMN Illumina | Maintains: Buy | n/a | $122.28 | - | 3 | Jul 31, 2018 |
GeneDx Holdings
Apr 22, 2024
Maintains: Buy
Price Target: $11 → $15
Current: $11.08
Upside: +35.38%
Adaptive Biotechnologies
Apr 4, 2024
Maintains: Buy
Price Target: $6 → $5
Current: $2.60
Upside: +92.31%
Cue Health
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.14
Upside: -
MaxCyte
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $3.71
Upside: +115.63%
Alpha Teknova
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.73
Upside: -
DermTech
Mar 7, 2024
Maintains: Buy
Price Target: $4 → $2
Current: $0.60
Upside: +231.62%
MDxHealth
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.47
Upside: +223.89%
SOPHiA GENETICS
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $5.03
Upside: +59.05%
NeoGenomics
Dec 29, 2023
Maintains: Buy
Price Target: $25 → $21
Current: $14.14
Upside: +48.51%
Natera
Dec 29, 2023
Maintains: Buy
Price Target: $75 → $85
Current: $91.66
Upside: -7.27%
Ginkgo Bioworks Holdings
Nov 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.86
Upside: -
Talis Biomedical
Aug 16, 2023
Maintains: Sell
Price Target: $0.35 → $5
Current: $9.14
Upside: -45.30%
Bionano Genomics
Aug 10, 2023
Maintains: Buy
Price Target: $2 → $10
Current: $0.79
Upside: +1,172.10%
Castle Biosciences
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $20.34
Upside: +47.49%
Renalytix
Apr 3, 2023
Maintains: Buy
Price Target: $4 → $3.5
Current: $0.63
Upside: +456.62%
Exagen
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $1.41
Upside: +254.11%
CareDx
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $7.56
Upside: +230.69%
Guardant Health
Feb 24, 2023
Maintains: Buy
Price Target: $60 → $50
Current: $17.35
Upside: +188.18%
Exact Sciences
Feb 22, 2023
Maintains: Buy
Price Target: $85 → $80
Current: $58.85
Upside: +35.94%
Cerus
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.71
Upside: -
Lucid Diagnostics
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $0.68
Upside: +412.37%
T2 Biosystems
Jul 7, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.84
Upside: -
Akoya Biosciences
Jun 22, 2022
Initiates: Buy
Price Target: $16
Current: $3.80
Upside: +321.05%
OncoCyte
Nov 30, 2020
Initiates: Buy
Price Target: n/a
Current: $2.48
Upside: -
Accelerate Diagnostics
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $0.93
Upside: -
Laboratory Corporation of America Holdings
Dec 3, 2018
Maintains: Hold
Price Target: n/a
Current: $198.40
Upside: -
Quest Diagnostics
Oct 24, 2018
Maintains: Buy
Price Target: n/a
Current: $134.26
Upside: -
Hologic
Sep 27, 2018
Maintains: Hold
Price Target: n/a
Current: $75.98
Upside: -
QuidelOrtho
Sep 10, 2018
Maintains: Buy
Price Target: n/a
Current: $39.64
Upside: -
Illumina
Jul 31, 2018
Maintains: Buy
Price Target: n/a
Current: $122.28
Upside: -